ATP-sensitive potassium (K ATP ) channels play a central role in glucosestimulated insulin secretion from pancreatic beta cells. Insulin secretion is initiated by closure of the channels and inhibited by their opening.
INTRODUCTION
ATP-sensitive potassium (K ATP ) channels play a central role in glucosestimulated insulin secretion from pancreatic beta cells. Insulin secretion is initiated by closure of the channels and inhibited by their opening. 1 The beta-cell K ATP channel is an octameric complex of four pore-forming, inwardly rectifying potassium-channel subunits (Kir6.2) and four regulatory sulfonylurea-receptor subunits (SUR1). Both Kir6.2 and SUR1 are required for correct metabolic regulation of the channel: ATP closes the channel by binding to Kir6.2, and magnesium nucleotides (Mg-ADP and Mg-ATP) stimulate channel activity by interacting with SUR1. Sulfonylureas stimulate insulin secretion in type2 diabetes by binding to SUR1 and closing K ATP channels by an ATP-independent mechanism.
2 Insulin receptor belongs to the class of tyrosine kinase receptor. The binding of insulin to its receptor causes conformational changes in the receptor leading to the activation of tyrosine kinase beta subunit. Insulin is responsible for phosphorylation of insulin receptor that leads to glucose uptake by the cells. Insulin is secreted by pancreatic islets in response to increase in blood glucose levels. Most cells of the body have insulin receptors which bind the insulin that is present in the blood circulation. When insulin is attached to insulin receptor of the cell, it initiates a cascade of events that mediates the absorption of glucose from the blood into the cell. 3 Phosphorylase kinase (PhK) is the regulatory enzyme responsible for catalyzing the rate limiting step in glycogen breakdown. PhK activates glycogen phosphorylase resulting in degradation of glycogen to glucose-1-phosphate. In liver, these reactions allow for the maintenance of blood glucose, and in muscle, they lead to energy production to sustain muscle contraction. It is comprised of four different subunits with a stoichiometry of (α,β, γ, δ).α,β, and δ are regulatory, while γ is catalytic. The α subunit is encoded by two different genes. 4, 5 The objective of the present study was to investigate the in silico antidiabetic effects of the isolated compound 1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl) -1 -(tetrahydro-6-(hydroxymethyl) -3,4,5-trimethoxy-2H-pyran-2-yloxy) cyclopenta (c) pyran -4 -carboxylic acid and 5,8-dihydro-7-isopentyl-2,3,5,8-tetramethoxynaphthalene-1,4,6-triol.
MATERIALS AND METHODS

Collection of plant materials
The root parts of S. tetragonum (family: Bignoniaceae) was collected from Tirunelveli district of Tamil Nadu, India and identified by the taxonomist of TBGRI and a voucher specimen (TBGRI 8282) has been deposited in the institute herbarium.
Aqueous extraction of dry powder
To prepare water extract, the powder S. tetragonum was extracted with distilled water (5 g/100 ml) by stirring for 4 hours and then filtering 
Isolation of an active fraction (AF)
The water extract of S. tetragonum root powder was precipitated with absolute ethanol (1:1 v/v) and separated into precipitate and soluble fractions. The soluble fraction was subjected to the preliminary phytochemical screening and isolation of compounds. In the present study, column chromatography and preparative TLC were used for elution of two compounds. Based on IR, H 1 NMR, 13 C NMR and Mass spectrum the compound was identified as 1, 4a, 5, 7a-tetrahydro-5-hydroxy -7-(hydroxymethyl) -1-(tetrahydro -6-(hydroxymethyl) -3, 4, 5-trimethoxy-2H-pyran-2-yloxy) cyclopenta (c) pyran-4-carboxylic acid (Figure 1 Figure 2 ) which was already published from our group 7 . The three dimensional structures of ATP-sensitive K+ channel, Insulin receptor and phosphorylase kinase were obtained from Protein Data bank (PDB): PDB ID:2WLK, 2B4s, 2Y7J.
Molecular docking
The structures considered for the study were obtained from the isolation of active fraction and from spectral studies. 1,4a,5,7a-tetrahydro-5-hydro xy-7-(hydroxymethyl)-1-(tetrahydro-6-(hydroxymethyl)-3,4,5-trimethoxy-2H-pyran-2-yloxy)cyclopenta [c]pyran-4-carboxylic acid (C1) and 5,8-dihydro-7-isopentyl-2,3,5,8-tetramethoxynaphthalene-1,4,6-triol (C2) were used as ligands and the structures were drawn using CHEMDRAW (Version 11). The structures of ATP-sensitive K+ channel, Insulin receptor and phosphorylase kinase were obtained from the protein data bank. Hydrogen atoms were added to the protein consistent with pH 7.0 using the protein preparation wizard in the Schrodinger suite. 8 Further, the protein's hydrogen bond network was also optimized using the wizard. The so-prepared structure was then subjected to energy minimization and the termination condition for minimization was fixed as the step when the root mean square deviation of the heavy atoms in the structure relative to the starting structure exceeded 0.3 A. This process also ensures that the hydrogen atoms are placed in optimized geometries. The protein thus prepared was used for docking of the ligands as described below. Potential binding sites in ATP sensitive K + channel, Insulin receptor and phosphorylase kinase were predicted using the Sitemap tool in the Schrodinger suite. 9, 10 Lig Prep module (version 2.5) of the Schrodinger suite was used to generate conformers of the ligands. The ligands were then docked using the extra precision mode in the Glide module [11] [12] [13] of the Schrodinger suite.
RESULTS AND DISCUSSION
Present studies provide scientific evidence that C1 and C2 strongly interact with ATP-sensitive K+ channel, Insulin receptor and phosphorylase kinase through different residues. Figure 3 shows the XP Glide score for both the compounds for ATP-sensitive K+ channel (-6.981 Kcal/mol for C1 and -9.425 Kcal/mol for C2) which clearly suggests that both the compounds show better interaction than metformin (Table.1 ). The docking of C1 and C2 with ATP-sensitive K+ channel resulted in the opening of Ca 2+ channels in pancreatic β cells causing Ca 2+ influx which might have facilitated the exocytosis of insulin from pancreatic β-cells, thus constituting in lowering the blood glucose level. Figure 4 shows the XP Glide score for both the compounds for Insulin receptor and were -7.882 Kcal/mol for C1 and -4.62 Kcal/mol for C2. This clearly suggests that both the compounds show better interaction than metformin (Table.1 ). Thus, the compounds could, possibly, activate the insulin receptor which facilitates the active absorption of glucose in skeletal muscle through GLUT4 and contributes in lowering the blood glucose. The XP Glide score for both the compounds for phosphorylase kinase is -6.164 Kcal/mol for C1 and -5.253 Kcal/mol for C2 ( Figure 5 ). This clearly suggests that docking of both the compounds with phosphorylase kinase lead to the inhibition of glycogenolysis by deactivating glycogen phosphorylase and thus resulting in the lowering of blood glucose level (Table 1) . In this context, the isolated compounds of S. tetragonum is likely to be useful as an alternative medicine or as a combination drug. There is a need to carry on further studies leading to likely development of the isolated compound as a standardized, safe and effective phytomedicine.
CONCLUSION
The results of the above investigation shows that these active molecules are very promising for further in-depth studies leading to the development of a novel, safe and valuable anti-hyperglycemic herbal drug medicine for mono-therapy and/or combination therapy for Diabetes mellitus.
